PIN1 and acute myeloid leukemia: As Pin1 degraders may have unparalleled benefits over conventional inhibitors in therapeutic treatment, our data suggest that P1D-34 can be a promising leading compounds and chemical probe for Pin1-related disease research, in addition to its potential use for the treatment of AML.